These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27713801)

  • 1. The association between institution at orchiectomy and outcomes on active surveillance for clinical stage I germ cell tumours.
    Nayan M; Jewett MA; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Sweet J; O'Malley M; Hamilton RJ
    Can Urol Assoc J; 2016; 10(5-6):204-209. PubMed ID: 27713801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
    Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
    J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
    Balzer BL; Ulbright TM
    Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer.
    Nayan M; Jewett MA; Hosni A; Anson-Cartwright L; Bedard PL; Moore M; Hansen AR; Chung P; Warde P; Sweet J; O'Malley M; Atenafu EG; Hamilton RJ
    Eur Urol; 2017 Jan; 71(1):120-127. PubMed ID: 27527805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
    Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
    Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
    Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
    J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
    Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
    J Pediatr Urol; 2017 Aug; 13(4):386.e1-386.e7. PubMed ID: 28153774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
    Lauritsen J; Sauvé N; Tryakin A; Jiang DM; Huddart R; Heng DYC; Terbuch A; Winquist E; Chovanec M; Hentrich M; Fankhauser CD; Shamash J; Del Muro XG; Vaughn D; Heidenreich A; Sternberg CN; Sweeney C; Necchi A; Bokemeyer C; Bandak M; Jandari A; Collette L; Gillessen S; Beyer J; Daugaard G
    Br J Cancer; 2023 Nov; 129(11):1759-1765. PubMed ID: 37777577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy.
    Mistretta FA; Mazzone E; Palumbo C; Knipper S; Tian Z; Nazzani S; Lattouf JB; Musi G; Perrotte P; Montanari E; Shariat SF; Montorsi F; Saad F; de Cobelli O; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Aug; 17(4):e793-e801. PubMed ID: 31182339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy in testicular germ cell tumours - a literature review.
    Jonska-Gmyrek J; Peczkowski P; Michalski W; Poniatowska G; Zolciak-Siwinska A; Kotowicz B; Wiechno P; Golawska M; Kowalska M; Demkow T
    Contemp Oncol (Pozn); 2017; 21(3):203-208. PubMed ID: 29180926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage II Testicular Seminoma: Patterns of Care and Survival by Treatment Strategy.
    Glaser SM; Vargo JA; Balasubramani GK; Beriwal S
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):513-21. PubMed ID: 27146264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
    Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
    World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 28-year late spermatic cord relapse of a testicular non-seminomatous germ cell tumour, managed robotically.
    Hayes JR; Jewett MA; Hamilton RJ
    Can Urol Assoc J; 2016; 10(7-8):E257-E260. PubMed ID: 28255418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node growth rate in testicular germ cell tumours: implications for computed tomography surveillance frequency.
    Mazrani W; O'Malley ME; Chung PW; Warde P; Vesprini D; Panzarella T
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):333-8. PubMed ID: 21084179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach.
    Lieng H; Warde P; Bedard P; Hamilton RJ; Hansen AR; Jewett MAS; O'malley M; Sweet J; Chung P
    Can Urol Assoc J; 2018 Feb; 12(2):59-66. PubMed ID: 29381453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and treatment outcomes of germ cell tumor in Jordan: A tertiary center experience.
    El-Achkar A; Alasadi H; El-Asmar J; Armache A; Abu-Hijlih R; Abu-Hijle F; Al-Ibraheem A; Khzouz J; Salah S; Shahait M
    Arab J Urol; 2023; 21(4):233-239. PubMed ID: 38178954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG).
    Germà-Lluch JR; Garcia del Muro X; Maroto P; Paz-Ares L; Arranz JA; Gumà J; Alba E; Sastre J; Aparicio J; Fernández A; Barnadas A; Terrassa J; Sáenz A; Almenar D; López-Brea M; Climent MA; Sánchez MA; Lasso de la Vega R; Berenguer G; Pérez X;
    Eur Urol; 2002 Dec; 42(6):553-62; discussion 562-3. PubMed ID: 12477650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.